STAT November 30, 2022
Jeff Allen and Lisa Lacasse

Cancer is becoming less deadly in America.

According to the recently released Annual Report to the Nation on the Status of Cancer, overall cancer death rates have continued to decline by about 2% per year over the last several years for Americans of all ages, races, and genders. The decline in cancer death rates is clearly welcome news and coincides with a significant shift in cancer treatment through the development of new targeted therapies and accompanying diagnostic tests that guide their use.

For decades, most cancers have been treated with toxic, cell-killing treatments that had limited ability to distinguish between cancerous and normal cells. While this approach often worked, it came with significant side effects and made treatment difficult to...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Patient / Consumer, Pharma / Biotech, Precision Medicine, Provider, Survey / Study, Trends
23andMe: What If …
23andMe CEO Anne Wojcicki considers taking company private
Age of Opportunity: Artificial Intelligence and the Precision Medicine Future
Opinion: Readers respond to OTC antidepressants, personalized medicine, restoring trust in public health, and more
Precision medicine approach combining AI, DNA and drug testing shows gains against relapsed childhood cancers

Share This Article